The biotechnology sector has fascinated me for a long time, and my experience working in "big pharma" only increased my interest. My goals with my research are simple - first and foremost, I strive to identify undervalued stocks that have future catalysts that can greatly push the price per share up. Another area that I focus on is combatting the "naysayers" - those individuals who either due to a lack of due diligence or who have ulterior motives - who spread news, gossip, and other misinformation. Most retail investors do not have an opportunity to conduct hours of research a day to sort through the vast array of information, and thus can be easily influenced by positive or negative information that may not be entirely accurate. In terms of my Seeking Alpha article writing, it is my hope to identify potential opportunities that may be overlooked, pitfalls that may be avoided, and to also generate discussion about potential deals or binary events that could impact investors in the biotech sector.